Elevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $600.00 target price on the stock. Several other equities research analysts have also issued reports on ELV. Barclays reduced their price target on Elevance Health from $621.00 […]
5 Oct 22:24 · The Markets Daily